Cargando…
Non-proteolytic ubiquitination of Hexokinase 2 by HectH9 controls tumor metabolism and cancer stem cell expansion
Enormous efforts have been made to target metabolic dependencies of cancer cells for developing new therapies. However, the therapeutic efficacy of glycolysis inhibitors is limited due to their inability to elicit cell death. Hexokinase 2 (HK2), via its mitochondrial localization, functions as a cen...
Autores principales: | Lee, Hong-Jen, Li, Chien-Feng, Ruan, Diane, He, Jiabei, Montal, Emily D., Lorenz, Sonja, Girnun, Geoffrey D., Chan, Chia-Hsin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6573064/ https://www.ncbi.nlm.nih.gov/pubmed/31201299 http://dx.doi.org/10.1038/s41467-019-10374-y |
Ejemplares similares
-
HectH9 hijacks glucose metabolism to fuel tumor growth
por: Lee, Hong-Jen, et al.
Publicado: (2019) -
A Genomic Survey of HECT Ubiquitin Ligases in Eukaryotes Reveals Independent Expansions of the HECT System in Several Lineages
por: Grau-Bové, Xavier, et al.
Publicado: (2013) -
Developing Small‐Molecule Inhibitors of HECT‐Type Ubiquitin Ligases for Therapeutic Applications: Challenges and Opportunities
por: Chen, Dan, et al.
Publicado: (2018) -
Evolution of Plant HECT Ubiquitin Ligases
por: Marín, Ignacio
Publicado: (2013) -
Reconstitution and Structural Analysis of a HECT Ligase-Ubiquitin
Complex via an Activity-Based Probe
por: Nair, Rahul M., et al.
Publicado: (2021)